Is Algorae Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Algorae Pharmaceuticals Ltd (1AI.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Algorae Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Algorae Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Algorae Pharmaceuticals Ltd?

Muslim investors may consider investing in Algorae Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Algorae Pharmaceuticals Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Algorae Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Algorae Pharmaceuticals Ltd updated?

The Shariah compliance status of Algorae Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Algorae Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Algorae Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Algorae Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

1AI.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 30, 2025

Report Source: 2025 2nd Quarter Report

Algorae Pharmaceuticals Ltd. Stock Analysis 1AI.AX

Australia Health Care Nano Cap Report: Q2, 2025

Algorae Pharmaceuticals Ltd. operates as an artificial intelligence enabled drug discovery and development company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-01. The Company’s proprietary AI platform, Algorae Operating System (AlgoraeOS), is an AI platform that leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. Its other drug candidates include AI-116, AI-168, NTCELL. AI-116 is a combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer’s disease. AI-168 is a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient, which is conceptualized to be a potential treatment for cardiovascular disease, including hypertension. NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells.

Key Statistics of Algorae Pharmaceuticals Ltd (1AI.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.01AUD0.01

Today's Open

AUD0.01

Volume

58.99K

P/E Ratio (TTM)

52 Week Range

AUD0.01AUD0.02

Market Cap

28.32M

Avg. Volume

2.00M

Dividend Yield

Financial Metrics & Statements of Algorae Pharmaceuticals Ltd (1AI.AX)

FAQ's for Algorae Pharmaceuticals Ltd (1AI.AX)

According to Musaffa’s Shariah screening methodology, Algorae Pharmaceuticals Ltd (1AI.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.